Last reviewed · How we verify

IV Caldolor

St. Joseph's Hospital and Medical Center, Phoenix · FDA-approved active Small molecule Quality 5/100

IV Caldolor is a Small molecule drug developed by St. Joseph's Hospital and Medical Center, Phoenix. It is currently FDA-approved. Also known as: IV ibuprofen, Opioid Sparing group.

At a glance

Generic nameIV Caldolor
Also known asIV ibuprofen, Opioid Sparing group
SponsorSt. Joseph's Hospital and Medical Center, Phoenix
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about IV Caldolor

What is IV Caldolor?

IV Caldolor is a Small molecule drug developed by St. Joseph's Hospital and Medical Center, Phoenix.

Who makes IV Caldolor?

IV Caldolor is developed and marketed by St. Joseph's Hospital and Medical Center, Phoenix (see full St. Joseph's Hospital and Medical Center, Phoenix pipeline at /company/st-joseph-s-hospital-and-medical-center-phoenix).

Is IV Caldolor also known as anything else?

IV Caldolor is also known as IV ibuprofen, Opioid Sparing group.

What development phase is IV Caldolor in?

IV Caldolor is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing